Annual SGA
$29.10 M
+$2.26 M+8.43%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual SGA is $29.10 million, with the most recent change of +$2.26 million (+8.43%) on December 31, 2023.
- During the last 3 years, CPIX annual SGA has risen by +$4.14 million (+16.59%).
- CPIX annual SGA is now -6.55% below its all-time high of $31.14 million, reached on December 31, 2017.
Performance
CPIX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.07 M
+$67.40 K+0.96%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly SGA is $7.07 million, with the most recent change of +$67.40 thousand (+0.96%) on September 30, 2024.
- Over the past year, CPIX quarterly SGA has dropped by -$1.13 million (-13.73%).
- CPIX quarterly SGA is now -18.00% below its all-time high of $8.63 million, reached on September 30, 2009.
Performance
CPIX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$79.51 M
-$10.87 M-15.84%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM SGA is -$79.51 million, with the most recent change of -$10.87 million (-15.84%) on September 30, 2024.
- Over the past year, CPIX TTM SGA has dropped by -$108.61 million (-373.18%).
- CPIX TTM SGA is now -202.57% below its all-time high of $77.52 million.
Performance
CPIX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CPIX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.4% | -13.7% | -373.2% |
| 3 y3 years | +16.6% | +21.1% | -414.6% |
| 5 y5 years | +20.5% | -1.5% | -414.9% |
CPIX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.4% | -13.7% | +12.7% | -684.9% | at low |
| 5 y | 5-year | at high | +17.4% | -13.7% | +23.1% | -753.2% | at low |
| alltime | all time | -6.5% | +253.4% | -18.0% | +263.5% | -202.6% | at low |
Cumberland Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.07 M(+1.0%) | $28.80 M(-0.0%) |
| Jun 2024 | - | $7.01 M(+7.4%) | $28.81 M(-0.1%) |
| Mar 2024 | - | $6.52 M(-20.4%) | $28.85 M(-0.9%) |
| Dec 2023 | $29.10 M(+8.4%) | $8.20 M(+15.7%) | $29.10 M(+4.7%) |
| Sep 2023 | - | $7.09 M(+0.6%) | $27.79 M(+3.0%) |
| Jun 2023 | - | $7.04 M(+3.9%) | $26.98 M(+1.1%) |
| Mar 2023 | - | $6.78 M(-1.6%) | $26.70 M(-0.5%) |
| Dec 2022 | $26.84 M(+8.3%) | $6.89 M(+9.7%) | $26.84 M(+0.6%) |
| Sep 2022 | - | $6.28 M(-7.2%) | $26.67 M(+1.7%) |
| Jun 2022 | - | $6.76 M(-2.3%) | $26.24 M(+2.1%) |
| Mar 2022 | - | $6.92 M(+3.0%) | $25.69 M(+3.6%) |
| Dec 2021 | $24.80 M(-0.7%) | $6.72 M(+15.0%) | $24.80 M(-1.9%) |
| Sep 2021 | - | $5.84 M(-6.1%) | $25.27 M(-0.5%) |
| Jun 2021 | - | $6.22 M(+3.3%) | $25.40 M(+0.6%) |
| Mar 2021 | - | $6.02 M(-16.3%) | $25.24 M(+1.1%) |
| Dec 2020 | $24.96 M(-1.1%) | $7.19 M(+20.5%) | $24.96 M(+0.0%) |
| Sep 2020 | - | $5.97 M(-1.4%) | $24.95 M(+0.5%) |
| Jun 2020 | - | $6.06 M(+5.4%) | $24.83 M(-0.8%) |
| Mar 2020 | - | $5.74 M(-20.0%) | $25.02 M(-0.9%) |
| Dec 2019 | $25.25 M(+4.5%) | $7.18 M(+22.9%) | $25.25 M(+20.6%) |
| Sep 2019 | - | $5.84 M(-6.5%) | $20.94 M(-4.7%) |
| Jun 2019 | - | $6.25 M(+4.7%) | $21.97 M(-5.0%) |
| Mar 2019 | - | $5.97 M(+107.9%) | $23.13 M(-4.3%) |
| Dec 2018 | $24.16 M(-22.4%) | $2.87 M(-58.2%) | $24.16 M(-18.7%) |
| Sep 2018 | - | $6.87 M(-7.3%) | $29.70 M(-4.6%) |
| Jun 2018 | - | $7.41 M(+5.9%) | $31.14 M(+1.3%) |
| Mar 2018 | - | $7.00 M(-16.8%) | $30.74 M(-1.3%) |
| Dec 2017 | $31.14 M(+34.7%) | $8.42 M(+1.2%) | $31.14 M(+5.8%) |
| Sep 2017 | - | $8.32 M(+18.7%) | $29.44 M(+10.7%) |
| Jun 2017 | - | $7.01 M(-5.3%) | $26.60 M(+7.5%) |
| Mar 2017 | - | $7.40 M(+10.3%) | $24.74 M(+7.0%) |
| Dec 2016 | $23.12 M(+7.0%) | $6.71 M(+22.5%) | $23.12 M(+6.2%) |
| Sep 2016 | - | $5.48 M(+6.5%) | $21.77 M(+0.4%) |
| Jun 2016 | - | $5.15 M(-10.9%) | $21.69 M(-2.3%) |
| Mar 2016 | - | $5.78 M(+7.7%) | $22.20 M(+2.8%) |
| Dec 2015 | $21.60 M | $5.37 M(-0.7%) | $21.60 M(-1.7%) |
| Sep 2015 | - | $5.40 M(-4.5%) | $21.98 M(-2.6%) |
| Jun 2015 | - | $5.66 M(+9.4%) | $22.56 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $5.18 M(-9.9%) | $22.97 M(-1.4%) |
| Dec 2014 | $23.30 M(-2.4%) | $5.74 M(-4.0%) | $23.30 M(-4.6%) |
| Sep 2014 | - | $5.98 M(-1.5%) | $24.42 M(+2.6%) |
| Jun 2014 | - | $6.07 M(+10.1%) | $23.81 M(+2.9%) |
| Mar 2014 | - | $5.51 M(-19.7%) | $23.14 M(-3.1%) |
| Dec 2013 | $23.88 M(-18.7%) | $6.86 M(+27.8%) | $23.88 M(-3.4%) |
| Sep 2013 | - | $5.37 M(-0.5%) | $24.71 M(-5.5%) |
| Jun 2013 | - | $5.40 M(-13.6%) | $26.15 M(-7.9%) |
| Mar 2013 | - | $6.25 M(-18.8%) | $28.39 M(-3.4%) |
| Dec 2012 | $29.39 M(-2.8%) | $7.70 M(+13.1%) | $29.39 M(+0.8%) |
| Sep 2012 | - | $6.81 M(-10.9%) | $29.16 M(-1.4%) |
| Jun 2012 | - | $7.64 M(+5.4%) | $29.57 M(-2.1%) |
| Mar 2012 | - | $7.25 M(-3.0%) | $30.20 M(-0.1%) |
| Dec 2011 | $30.25 M(-1.7%) | $7.47 M(+3.6%) | $30.25 M(-2.2%) |
| Sep 2011 | - | $7.21 M(-12.9%) | $30.93 M(-0.9%) |
| Jun 2011 | - | $8.28 M(+13.5%) | $31.22 M(+2.1%) |
| Mar 2011 | - | $7.29 M(-10.6%) | $30.58 M(-0.6%) |
| Dec 2010 | $30.77 M(+10.5%) | $8.15 M(+8.7%) | $30.77 M(+0.5%) |
| Sep 2010 | - | $7.50 M(-1.7%) | $30.63 M(-3.5%) |
| Jun 2010 | - | $7.63 M(+1.9%) | $31.75 M(+6.8%) |
| Mar 2010 | - | $7.49 M(-6.5%) | $29.74 M(+6.8%) |
| Dec 2009 | $27.84 M(+42.6%) | $8.01 M(-7.2%) | $27.84 M(+9.4%) |
| Sep 2009 | - | $8.63 M(+53.5%) | $25.46 M(+17.8%) |
| Jun 2009 | - | $5.62 M(+0.6%) | $21.62 M(+4.6%) |
| Mar 2009 | - | $5.58 M(-0.7%) | $20.66 M(+5.8%) |
| Dec 2008 | $19.53 M(+37.6%) | $5.63 M(+17.5%) | $19.53 M(+9.0%) |
| Sep 2008 | - | $4.79 M(+2.6%) | $17.92 M(+8.8%) |
| Jun 2008 | - | $4.67 M(+4.9%) | $16.47 M(+8.3%) |
| Mar 2008 | - | $4.45 M(+10.7%) | $15.20 M(+7.1%) |
| Dec 2007 | $14.19 M(+37.1%) | $4.02 M(+20.4%) | $14.19 M(+2.4%) |
| Sep 2007 | - | $3.34 M(-2.0%) | $13.86 M(+5.7%) |
| Jun 2007 | - | $3.40 M(-1.0%) | $13.11 M(+10.7%) |
| Mar 2007 | - | $3.44 M(-6.8%) | $11.84 M(+14.4%) |
| Dec 2006 | $10.35 M(+25.7%) | $3.69 M(+42.7%) | $10.35 M(+55.4%) |
| Sep 2006 | - | $2.58 M(+21.3%) | $6.66 M(+63.4%) |
| Jun 2006 | - | $2.13 M(+9.5%) | $4.08 M(+109.5%) |
| Mar 2006 | - | $1.95 M | $1.95 M |
| Dec 2005 | $8.24 M | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual SGA year-on-year change?
- What is Cumberland Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly SGA year-on-year change?
- What is Cumberland Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM SGA year-on-year change?
What is Cumberland Pharmaceuticals annual SGA?
The current annual SGA of CPIX is $29.10 M
What is the all time high annual SGA for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual SGA is $31.14 M
What is Cumberland Pharmaceuticals annual SGA year-on-year change?
Over the past year, CPIX annual SGA has changed by +$2.26 M (+8.43%)
What is Cumberland Pharmaceuticals quarterly SGA?
The current quarterly SGA of CPIX is $7.07 M
What is the all time high quarterly SGA for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly SGA is $8.63 M
What is Cumberland Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, CPIX quarterly SGA has changed by -$1.13 M (-13.73%)
What is Cumberland Pharmaceuticals TTM SGA?
The current TTM SGA of CPIX is -$79.51 M
What is the all time high TTM SGA for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM SGA is $77.52 M
What is Cumberland Pharmaceuticals TTM SGA year-on-year change?
Over the past year, CPIX TTM SGA has changed by -$108.61 M (-373.18%)